All In MedTech

FDA Clearance Tracker · P990054

CHILLI COOLED ABLATION SYSTEM

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Mar 17, 2000 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Mar 17, 2000

Approval withdrawn

Time to decision

179 days

Received Sep 20, 1999. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P990054
Device name
CHILLI COOLED ABLATION SYSTEM
Applicant location
San Jose, CA
Received
Sep 20, 1999
Decided
Mar 17, 2000
Decision
Approval withdrawn
Supplements
7 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code LPB

FDA's approval statement

As written in FDA's record.

The Chilli Cooled Ablation System is indicated for cardiac electrophysiological mapping, delivering diagnostic pacing stimuli, RF ablation of mappable ventricular tachycardias attributable to ischemic heart disease or cardiomyopathy in patients who have failed drug therapy. In addition, the Chilli Catheter with Tracking is used with the Arrhythmia Mapping and Tracking System to provide catheter location information.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code LPB. The earliest in FDA's data is P920047, decided Oct 28, 1994.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Boston Scientific Corp

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.